BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 37891450)

  • 1. Left ventricular fibrosis and CMR tissue characterization of papillary muscles in mitral valve prolapse patients.
    Spampinato RA; Marin-Cuartas M; van Kampen A; Fahr F; Sieg F; Strotdrees E; Jahnke C; Klaeske K; Wiesner K; Morningstar JE; Nagata Y; Izquierdo-Garcia D; Dieterlen MT; Norris RA; Levine RA; Paetsch I; Borger MA
    Int J Cardiovasc Imaging; 2024 Feb; 40(2):213-224. PubMed ID: 37891450
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Left Ventricular Fibrosis and CMR Tissue Characterization of Papillary Muscles in Mitral Valve Prolapse Patients.
    Spampinato RA; Marin-Cuartas M; Kampen A; Fahr F; Sieg F; Strotdrees E; Jahnke C; Klaeske K; Wiesner K; Morningstar JE; Nagata Y; Izquierdo-Garcia D; Dieterlen MT; Norris RA; Levine RA; Paetsch I; Borger MA
    Res Sq; 2023 May; ():. PubMed ID: 37292932
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dark-blood late gadolinium enhancement CMR improves detection of papillary muscle fibrosis in patients with mitral valve prolapse.
    Van De Heyning CM; Holtackers RJ; Nazir MS; Grapsa J; Demetrescu C; Pype L; Chiribiri A
    Eur J Radiol; 2022 Feb; 147():110118. PubMed ID: 34972057
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiovascular magnetic resonance characterization of mitral valve prolapse.
    Han Y; Peters DC; Salton CJ; Bzymek D; Nezafat R; Goddu B; Kissinger KV; Zimetbaum PJ; Manning WJ; Yeon SB
    JACC Cardiovasc Imaging; 2008 May; 1(3):294-303. PubMed ID: 19356441
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Late Gadolinium Enhancement of Left Ventricular Papillary Muscles in Patients with Mitral Regurgitation.
    Lim SJ; Koo HJ; Cho MS; Nam GB; Kang JW; Yang DH
    Korean J Radiol; 2021 Oct; 22(10):1609-1618. PubMed ID: 34402246
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiac magnetic resonance in patients with mitral valve prolapse: Focus on late gadolinium enhancement and T1 mapping.
    Pradella S; Grazzini G; Brandani M; Calistri L; Nardi C; Mori F; Miele V; Colagrande S
    Eur Radiol; 2019 Mar; 29(3):1546-1554. PubMed ID: 30088066
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myocardial extracellular volume by T1 mapping: a new marker of arrhythmia in mitral valve prolapse.
    Pavon AG; Arangalage D; Pascale P; Hugelshofer S; Rutz T; Porretta AP; Le Bloa M; Muller O; Pruvot E; Schwitter J; Monney P
    J Cardiovasc Magn Reson; 2021 Sep; 23(1):102. PubMed ID: 34517908
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diffuse myocardial fibrosis in patients with mitral valve prolapse and ventricular arrhythmia.
    Bui AH; Roujol S; Foppa M; Kissinger KV; Goddu B; Hauser TH; Zimetbaum PJ; Ngo LH; Manning WJ; Nezafat R; Delling FN
    Heart; 2017 Feb; 103(3):204-209. PubMed ID: 27515954
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dark papillary muscles sign: a novel prognostic marker for cardiac magnetic resonance.
    Aquaro GD; De Gori C; Grilli G; Licordari R; Barison A; Todiere G; Ianni U; Parollo M; Grigoratos C; Restivo L; De Luca A; Faggioni L; Cioni D; Sinagra G; Di Bella G; Neri E
    Eur Radiol; 2023 Jul; 33(7):4621-4636. PubMed ID: 36692598
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Morphofunctional Abnormalities of Mitral Annulus and Arrhythmic Mitral Valve Prolapse.
    Perazzolo Marra M; Basso C; De Lazzari M; Rizzo S; Cipriani A; Giorgi B; Lacognata C; Rigato I; Migliore F; Pilichou K; Cacciavillani L; Bertaglia E; Frigo AC; Bauce B; Corrado D; Thiene G; Iliceto S
    Circ Cardiovasc Imaging; 2016 Aug; 9(8):e005030. PubMed ID: 27516479
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Replacement Myocardial Fibrosis in Patients With Mitral Valve Prolapse: Relation to Mitral Regurgitation, Ventricular Remodeling, and Arrhythmia.
    Constant Dit Beaufils AL; Huttin O; Jobbe-Duval A; Senage T; Filippetti L; Piriou N; Cueff C; Venner C; Mandry D; Sellal JM; Le Scouarnec S; Capoulade R; Marrec M; Thollet A; Beaumont M; Hossu G; Toquet C; Gourraud JB; Trochu JN; Warin-Fresse K; Marie PY; Schott JJ; Roussel JC; Serfaty JM; Selton-Suty C; Le Tourneau T
    Circulation; 2021 May; 143(18):1763-1774. PubMed ID: 33706538
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of papillary muscle function using cardiovascular magnetic resonance imaging in mitral valve prolapse.
    Han Y; Peters DC; Kissinger KV; Goddu B; Yeon SB; Manning WJ; Nezafat R
    Am J Cardiol; 2010 Jul; 106(2):243-8. PubMed ID: 20599010
    [TBL] [Abstract][Full Text] [Related]  

  • 13. T1 mapping and cardiac magnetic resonance feature tracking in mitral valve prolapse.
    Guglielmo M; Fusini L; Muscogiuri G; Baessato F; Loffreno A; Cavaliere A; Rizzon G; Baggiano A; Rabbat MG; Muratori M; Tamborini G; Danza LML; Del Torto A; Tonet E; Viani G; Mushtaq S; Conte E; Bonalumi G; Gripari P; Zanobini M; Andreini D; Alamanni F; Pepi M; Guaricci AI; Pontone G
    Eur Radiol; 2021 Feb; 31(2):1100-1109. PubMed ID: 32803414
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Electrical markers and arrhythmic risk associated with myocardial fibrosis in mitral valve prolapse.
    Chivulescu M; Aabel EW; Gjertsen E; Hopp E; Scheirlynck E; Cosyns B; Lyseggen E; Edvardsen T; Lie ØH; Dejgaard LA; Haugaa KH
    Europace; 2022 Jul; 24(7):1156-1163. PubMed ID: 35226070
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transthoracic echocardiography for arrhythmic mitral valve prolapse: Phenotypic characterization as first step.
    Vriz O; Eltayeb A; Landi I; Anwar K; Alenazy A; Hiristova K; Kasprzak J; D'Andrea A; Amro B; Limongelli G; Bossone E; Imazio M
    Echocardiography; 2022 Sep; 39(9):1158-1170. PubMed ID: 36029124
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Feature tracking myocardial strain analysis in patients with bileaflet mitral valve prolapse: relationship with LGE and arrhythmias.
    Gatti M; Palmisano A; Esposito A; Fiore S; Monti CB; Andreis A; Pistelli L; Vergara P; Bergamasco L; Giustetto C; De Cobelli F; Fonio P; Faletti R
    Eur Radiol; 2021 Oct; 31(10):7273-7282. PubMed ID: 33870458
    [TBL] [Abstract][Full Text] [Related]  

  • 17. T
    Maforo NG; Magrath P; Moulin K; Shao J; Kim GH; Prosper A; Renella P; Wu HH; Halnon N; Ennis DB
    J Cardiovasc Magn Reson; 2020 Dec; 22(1):85. PubMed ID: 33302967
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mitral Valve Prolapse and Sudden Cardiac Death in Athletes at High Risk.
    Vriz O; Landi I; Eltayeb A; Limongelli G; Mos L; Delise P; Bossone E; D Andrea A
    Curr Cardiol Rev; 2023; 19(3):e201222212066. PubMed ID: 36545732
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Abnormal Papillary Muscle Signal on Cine MRI As a Typical Feature of Mitral Valve Prolapse.
    Scatteia A; Pascale CE; Gallo P; Pezzullo S; America R; Cappelletti AM; Dalla Vecchia LA; Guarini P; Dellegrottaglie S
    Sci Rep; 2020 Jun; 10(1):9166. PubMed ID: 32513938
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Imaging characteristics of papillary muscle site of origin of ventricular arrhythmias in patients with mitral valve prolapse.
    Fulton BL; Liang JJ; Enriquez A; Garcia FC; Supple GE; Riley MP; Schaller RD; Dixit S; Callans DJ; Marchlinski FE; Han Y
    J Cardiovasc Electrophysiol; 2018 Jan; 29(1):146-153. PubMed ID: 29059484
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.